Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01977235
What this trial is testing

Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Third Military Medical University 110
Early research (Phase 1)Study completedNCT00388089
What this trial is testing

Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 24
Testing effectiveness (Phase 2)Study completedNCT00773955
What this trial is testing

R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT02913443
What this trial is testing

A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)

Who this might be right for
Small Cell Lung Cancer
Hoffmann-La Roche 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07141771
What this trial is testing

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Who this might be right for
SCLC, Extensive Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 100
Testing effectiveness (Phase 2)UnknownNCT05901584
What this trial is testing

Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC

Who this might be right for
ImmunotherapySecond-line Treatment
Second Affiliated Hospital of Zunyi Medical University 30
Early research (Phase 1)Looking for participantsNCT06613009
What this trial is testing

Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 190
Testing effectiveness (Phase 2)Study completedNCT00616109
What this trial is testing

Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
University of Michigan Rogel Cancer Center 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07376499
What this trial is testing

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Who this might be right for
Small Cell Lung Cancer
China Medical University, China 31
Large-scale testing (Phase 3)Study completedNCT02763579
What this trial is testing

Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Carcinoma
Hoffmann-La Roche 503
Testing effectiveness (Phase 2)UnknownNCT06350162
What this trial is testing

Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC

Who this might be right for
Extensive Stage Lung Small Cell Cancer
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06177925
What this trial is testing

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Who this might be right for
Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by Site+7 more
Nanfang Hospital, Southern Medical University 62
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06419179
What this trial is testing

Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Carcinoma
University of Cologne 29
Early research (Phase 1)Temporarily pausedNCT05403723
What this trial is testing

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
University of Maryland, Baltimore 50
Testing effectiveness (Phase 2)UnknownNCT05354700
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Shanghai Henlius Biotech 20
Early research (Phase 1)Study completedNCT00019006
What this trial is testing

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

Who this might be right for
Recurrent Colon CancerExtensive Stage Small Cell Lung CancerStage III Pancreatic Cancer+11 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT06812260
What this trial is testing

A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Shanghai Henlius Biotech 26
Not applicableStudy completedNCT04854590
What this trial is testing

IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell
AstraZeneca 248
Large-scale testing (Phase 3)Active Not RecruitingNCT05468489
What this trial is testing

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Shanghai Henlius Biotech 200
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Next Page